Compare AAME & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | AAME | ICCM |
|---|---|---|
| Founded | 1968 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Life Insurance | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.4M | 41.4M |
| IPO Year | 1995 | 2013 |
| Metric | AAME | ICCM |
|---|---|---|
| Price | $1.73 | $4.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 4.9K | ★ 1.1M |
| Earning Date | 05-12-2026 | 05-27-2026 |
| Dividend Yield | ★ 0.81% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.22 | N/A |
| Revenue | ★ $188,227,000.00 | N/A |
| Revenue This Year | N/A | $139.51 |
| Revenue Next Year | N/A | $75.66 |
| P/E Ratio | $8.45 | ★ N/A |
| Revenue Growth | ★ 0.77 | N/A |
| 52 Week Low | $1.67 | $0.13 |
| 52 Week High | $3.71 | $5.69 |
| Indicator | AAME | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 21.42 | 86.13 |
| Support Level | N/A | $0.56 |
| Resistance Level | $3.16 | N/A |
| Average True Range (ATR) | 0.09 | 0.20 |
| MACD | -0.05 | 0.46 |
| Stochastic Oscillator | 1.72 | 80.05 |
Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.